Mount Sinai researchers found that popular AI chatbots like ChatGPT and DeepSeek R1 can generate convincing but false medical information when given even a single fabricated term in a prompt. While the study underscored the need for stronger safeguards, its lead author noted that generative AI still holds major promise for reducing clinician workload if…
Navitus Health Solutions is launching a cost-plus pricing model through Costco Pharmacy. It will become available for clients starting in January for prescriptions filled at retail and mail order locations. The post Navitus, Costco Pharmacy Team Up for Cost-Plus Pricing Model appeared first on MedCity News.
By MATTHEW HOLT I moved over something I wrote on linkedin, so that it doesn’t vanish. I do this type of thing so you don’t have to & to make Brett Jansen happy I am writing in one line paragraphs. My question, is how doo LabCorp, Brown & Toland and Blue Shield Of California come…
Se suponía que iba a ser más fácil. Cuando la Ley de Cuidado de Salud a Bajo Precio (ACA) se aprobó en marzo de 2010, el objetivo era ayudar a que más personas en el país obtuvieran seguro médico. Y, de hecho, la creación de mercados en línea y la ampliación de los criterios de…
This tracker provides an overview of state laws/policies restricting minor access to gender affirming care and any associated litigation by state, identifying which groups of people are impacted in addition to minors, the types of penalties providers face, the status of legal challenges, and other key information.
Boehringer-Ingelheim pill Hernexeos was awarded accelerated FDA approval for advanced cases of non-small cell lung cancer with HER2 mutations. But Bayer is on its heels with an oral small molecule currently under FDA review in the same indication. The post FDA Nod Makes Boehringer Ingelheim Drug an Alternative to AstraZeneca ADC in Lung Cancer appeared…
A new analysis shows that individuals with employer insurance could save 41% on their out-of-pocket spending for asthma and COPD inhalers through manufacturer savings. In response to a U.S. Senate investigation into inhaler costs, 3 drug makers voluntarily capped out-of-pocket costs on their brand-name asthma and COPD inhalers.
As CMS ramps up its RADV initiatives in the months ahead, plans should ensure their risk adjustment programs meet the highest standards of accuracy and compliance. Prospective and retrospective analytics enhanced by AI can help plans work with providers to optimize documentation at the point of care and identify coding errors during audit preparation. The…
Our industry must guard against the weaponization of supply chain resilience in healthcare purchasing. The post Health Systems’ Escalating Demands for Supply Chain Resilience Have Become Counterproductive appeared first on MedCity News.
Amid the challenges of adulthood, one rite of passage is unique to the United States: the need to find your own health insurance by the time you turn 26. That is the age at which the Affordable Care Act declares that young adults generally must get off their family’s plan and figure out their coverage…